Minimally Invasive Surgical (MIS) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Minimally Invasive Surgical (MIS) Devices Pipeline Market Report Overview

Minimally invasive surgery (MIS) is a term used to describe either a smaller incision (typically half of the length of the traditional incision) or an approach that does not involve cutting tendons or splitting muscles.

The MIS devices pipeline market research report comprehensive information about the MIS devices pipeline products with a comparative analysis of the products at various stages of development. The report also includes information about the clinical trials which are in progress.

Key Territories ·       The US

·       Europe

·       China

·       Israel

·       Uzbekistan

·       Australia

Key Regulatory Paths ·       510(k)

·       NMPA

·       CE

·       TGA

Leading Companies ·       Actuated Medical Inc

·       BariaTek Medical SAS

·       Boston Scientific Corp

·       Delft University of Technology

·       Distalmotion SA

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

MIS Devices Pipeline Market Segmentation by Territories

The key territories in the MIS devices pipeline market are the US, Europe, China, Israel, Uzbekistan, and Australia. As of July 2024, the US accounts for the highest number of pipeline products.

MIS Devices Pipeline Market Analysis by Territories, 2024 (%)

MIS Devices Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the MIS Devices Pipeline Market

Download a Free Report Sample

MIS Devices Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the MIS devices pipeline products market are 510(k), CE, TGA, and NMPA. As of July 2024, 510(k) is the most followed pathway for pipeline products in the MIS devices market.

MIS Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

MIS Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the MIS Devices Pipeline Market

Download a Free Report Sample

MIS Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the MIS devices pipeline market are Actuated Medical Inc., BariaTek Medical SAS, Boston Scientific Corp, Delft University of Technology, and     Distalmotion SA, among others.

Actuated Medical Inc.: Headquartered in Bellefonte, Pennsylvania, the US, it is a medical device company that develops minimally invasive instruments. The company provides products such as controlled tissue penetration systems, occlusion clearing systems, and MRI-compatible systems. Its controlled tissue penetration systems use low force, electronically controlled motion to enable smooth insertion of sharps for serial blood sampling procedures.

BariaTek Medical SAS: BariaTek Medical SAS (BariaTek Medical) is a medical technology company that develops minimally invasive devices implantable through endoscopy to diagnose the bariatric surgery effect. BariaTek Medical is headquartered in Paris, France.

Boston Scientific Corp: Headquartered in Marlborough, Massachusetts, the US, it is a medical technology company that develops, manufactures, and commercializes devices for a range of interventional medical specialties. The company offers products in the areas of electrophysiology, gastroenterology, gastrointestinal surgery, and female pelvic medicine, among others. Boston Scientific serves hospitals, clinics, outpatient facilities, and medical offices across the world.

MIS Devices Pipeline Market Analysis by Companies, 2024

MIS Devices Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the MIS Devices Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

MIS Devices Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Israel
  • Uzbekistan
  • Australia

MIS Devices Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • NMPA
  • TGA

Scope

This report provides:

  • Extensive coverage of the Minimally Invasive Surgical (MIS) devices under development.
  • Details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities.
  • Reviews of the major players involved in the development of Minimally Invasive Surgical (MIS) devices and list all their pipeline projects.
  • The coverage of pipeline products is based on various stages of development ranging from Early Development to Approved / Issued stage.
  • Key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of Minimally Invasive Surgical (MIS) devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Actuated Medical Inc
BariaTek Medical SAS
Boston Scientific Corp
Delft University of Technology
Distalmotion SA
Eindhoven University of Technology
ES Vascular Ltd.
Ethicon Endo-Surgery Inc
Ezisurg Medical Co Ltd
GT Metabolic Solutions
Intuitive Surgical Inc
Jiangsu Jiyuan Medical Technology Co Ltd
Johns Hopkins University
Lapovations LLC
LXS Inc
Medacta Group SA
Osaka University
Patch Clamp Med Tech Inc
Prana Thoracic Inc
Purdue University
Qingdao Jianxin Medical Technology Co Ltd
Rambam Health Care Campus
Ruilong Ruilong Nuofu (Shanghai) Medical Technology Co Ltd
Stanford University
UltraSurge Technologies Ltd.
University of South Florida
University of Wisconsin Madison
Varada Innovations Inc.
VenX Medical LLC (Inactive)
Virginia Commonwealth University
West Virginia University

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 9

2 Introduction 10

2.1 Minimally Invasive Surgical (MIS) devices Overview 10

3 Products under Development 11

3.1 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 11

3.2 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Territory 12

3.3 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Regulatory Path 13

3.4 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Estimated Approval Date 14

3.5 Minimally Invasive Surgical (MIS) devices – Ongoing Clinical Trials 15

4 Minimally Invasive Surgical (MIS) devices – Pipeline Products under Development by Companies 16

4.1 Minimally Invasive Surgical (MIS) devices Companies – Pipeline Products by Stage of Development 16

4.2 Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 18

5 Minimally Invasive Surgical (MIS) devices Companies and Product Overview 19

5.1 Actuated Medical Inc Company Overview 19

5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 BariaTek Medical SAS Company Overview 20

5.2.1 BariaTek Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 Boston Scientific Corp Company Overview 23

5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Delft University of Technology Company Overview 24

5.4.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Distalmotion SA Company Overview 26

5.5.1 Distalmotion SA Pipeline Products & Ongoing Clinical Trials Overview 26

5.6 Eindhoven University of Technology Company Overview 28

5.6.1 Eindhoven University of Technology Pipeline Products & Ongoing Clinical Trials Overview 28

5.7 ES Vascular Ltd. Company Overview 29

5.7.1 ES Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Ethicon Endo-Surgery Inc Company Overview 30

5.8.1 Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 Ezisurg Medical Co Ltd Company Overview 31

5.9.1 Ezisurg Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 GT Metabolic Solutions Company Overview 32

5.10.1 GT Metabolic Solutions Pipeline Products & Ongoing Clinical Trials Overview 32

5.11 Intuitive Surgical Inc Company Overview 36

5.11.1 Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.12 Jiangsu Jiyuan Medical Technology Co Ltd Company Overview 37

5.12.1 Jiangsu Jiyuan Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

5.13 Johns Hopkins University Company Overview 38

5.13.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Lapovations LLC Company Overview 39

5.14.1 Lapovations LLC Pipeline Products & Ongoing Clinical Trials Overview 39

5.15 LXS Inc Company Overview 40

5.15.1 LXS Inc Pipeline Products & Ongoing Clinical Trials Overview 40

5.16 Medacta Group SA Company Overview 41

5.16.1 Medacta Group SA Pipeline Products & Ongoing Clinical Trials Overview 41

5.17 Osaka University Company Overview 42

5.17.1 Osaka University Pipeline Products & Ongoing Clinical Trials Overview 42

5.18 Patch Clamp Med Tech Inc Company Overview 43

5.18.1 Patch Clamp Med Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.19 Prana Thoracic Inc Company Overview 44

5.19.1 Prana Thoracic Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.20 Purdue University Company Overview 45

5.20.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 45

5.21 Qingdao Jianxin Medical Technology Co Ltd Company Overview 46

5.21.1 Qingdao Jianxin Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

5.22 Rambam Health Care Campus Company Overview 47

5.22.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 47

5.23 Ruilong Ruilong Nuofu (Shanghai) Medical Technology Co Ltd Company Overview 48

5.23.1 Ruilong Ruilong Nuofu (Shanghai) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

5.24 Stanford University Company Overview 49

5.24.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 49

5.25 UltraSurge Technologies Ltd. Company Overview 50

5.25.1 UltraSurge Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50

5.26 University of South Florida Company Overview 51

5.26.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 51

5.27 University of Wisconsin Madison Company Overview 52

5.27.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 52

5.28 Varada Innovations Inc. Company Overview 53

5.28.1 Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview 53

5.29 VenX Medical LLC (Inactive) Company Overview 54

5.29.1 VenX Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54

5.30 Virginia Commonwealth University Company Overview 55

5.30.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 55

5.31 West Virginia University Company Overview 56

5.31.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 56

6 Minimally Invasive Surgical (MIS) devices- Recent Developments 58

6.1 Jul 15, 2024: GT Metabolic Solutions Receives De Nova Clearance For MagDI System 58

6.2 Jul 15, 2024: Signum Surgical Receives De Nova Clearance For BioHealx Device 58

6.3 Jul 08, 2024: CONMED to Announce Second Quarter 2024 Financial Results on July 31, 2024 58

6.4 Jul 04, 2024: Signum Surgical’s BioHealx technology obtains FDA clearance 58

6.5 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024 59

6.6 Jun 26, 2024: Medtronic Announces Departure of Karen Parkhill, Chief Financial Officer 59

6.7 Jun 26, 2024: Medtronic CFO Transition and Interim Appointment Update 59

6.8 Jun 25, 2024: PatchClamp and PCS to develop new dural repair graft system 59

6.9 Jun 25, 2024: PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET 60

6.10 Jun 17, 2024: Medtronic EVP, Global Regions President Rob ten Hoedt is Retiring 60

6.11 Jun 13, 2024: Medtronic Confirms Global Layoffs 60

6.12 Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team 61

6.13 Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024 61

6.14 May 13, 2024: Fractyl Health Reports First Quarter 2024 Financial Results 61

6.15 May 07, 2024: Globus Medical Reports First Quarter 2024 Results 63

6.16 Apr 26, 2024: Mentice to Present the Company’s Q1 Interim Report 64

6.17 Apr 26, 2024: Intuitive Surgical Announces Board Changes 64

6.18 Apr 25, 2024: CONMED Promotes Patrick Beyer to Chief Operating Officer 64

6.19 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer 64

6.20 Apr 16, 2024: G Surgical Receives Additional FDA 510(k) Clearance for G Surgical Marksman MIS System 65

6.21 Apr 02, 2024: Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes 65

6.22 Mar 29, 2024: Titan Medical Reports Fiscal Year 2023 Results 65

6.23 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 66

6.24 Feb 28, 2024: Integra LifeSciences Announces Leadership Transition Plan 66

6.25 Feb 21, 2024: Surgical Science Sweden Announces Year-end report 2023: Strong License Revenue, Weaker Simulator Sales 67

6.26 Feb 20, 2024: Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita® Pivotal Clinical Trials 68

6.27 Feb 06, 2024: BariaTek Medical Announces the First-in-Human Implantation of Its BariTon Device, a Non-Surgical Gastro-Intestinal Medical Device Aiming to Replicate the Efficacy of Obesity Surgery Without the Invasiveness 68

6.28 Jan 31, 2024: Stryker Corp Reports Strong Q4 and Full Year 2023 Results; Forecasts Continued Growth 69

6.29 Jan 24, 2024: Intuitive Surgical Reports Results for the Quarter Ended in December 69

6.30 Jan 23, 2024: Intuitive Surgical Announces Non-GAAP EPS of $1.60 Beats by $0.11, Revenue of $1.93b Beats by $30M 70

6.31 Dec 22, 2023: Department of Urology at Soonchunhyang University Bucheon Hospital Achieves 1,000 Cases of Da Vinci Xi Robotic Surgery 70

6.32 Dec 07, 2023: Industry Leader Greg Roche Joins Distalmotion as CEO 70

6.33 Dec 05, 2023: Surgical Innovations Group Announces Directorate Change 71

6.34 Nov 22, 2023: Mentice Appoints Ulrika Drotz Voksepp as New Chief Financial Officer, Effective January 2, 2024 72

6.35 Nov 14, 2023: PetVivo Reports Second Quarter of Fiscal 2024 Financial Results 72

6.36 Nov 09, 2023: Petvivo Holdings to Announce Results for the Second Quarter Ended September 30, 2023 73

6.37 Nov 01, 2023: Intuitive Appoints Align Technology Exec to its Board 74

6.38 Oct 31, 2023: CONMED Corp. to Participate in Fireside Chats at Two Investor Conferences on November 14-15 74

6.39 Oct 31, 2023: Intuitive Appoints Sreelakshmi Kolli to its Board of Directors 75

6.40 Oct 26, 2023: Stille AB: Interim Report Q3 2023 75

6.41 Oct 25, 2023: Surgical Science Sweden Announces Conference Call Regarding Interim Report Q3 Results 76

6.42 Oct 19, 2023: Mentice’s CEO Goran Malmberg to Present the Company’s Interim Report During a Live Webcast on October 26 at 10:00 CEST 76

6.43 Oct 12, 2023: Intuitive Surgical Scheduled to Post Quarterly Earnings on Thursday 76

6.44 Oct 09, 2023: Stryker to Host Investor Day 76

6.45 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 77

6.46 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023 77

6.47 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer 77

6.48 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources 78

6.49 Sep 08, 2023: Mentice Strengthens Leadership Team with the Appointment of Chief Operating Officer (COO) 78

6.50 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 78

6.51 Aug 24, 2023: Surgial Science Sweden Announces Interim Report January – June 2023 79

6.52 Aug 14, 2023: Titan Medical Announces Appointment of Daniel O’Brien to its Board of Directors 79

6.53 Aug 10, 2023: PetVivo Reports First Quarter of Fiscal 2024 Financial Results 79

6.54 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 81

6.55 Aug 01, 2023: Acclarent Receives Additional 510(k) Clearance for TruDi Navigation System 81

7 Appendix 82

7.1 Methodology 82

7.2 About GlobalData 85

7.3 Contact Us 85

7.4 Disclaimer 85

Table

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 11

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Territory 12

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Regulatory Path 13

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Estimated Approval Date 14

Minimally Invasive Surgical (MIS) devices – Ongoing Clinical Trials 15

Minimally Invasive Surgical (MIS) devices Companies – Pipeline Products by Stage of Development 16

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 18

Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Grip-Act-Reposition (GAR) Miniaturized Stable Working System – Product Status 19

Grip-Act-Reposition (GAR) Miniaturized Stable Working System – Product Description 19

BariaTek Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 20

BariTon – Product Status 20

BariTon – Product Description 20

BariaTek Medical SAS – Ongoing Clinical Trials Overview 21

BariTon – Clinical Feasibility Study of the BariTon System in Obese or Overweight (BMI > 27) Patients 22

BariTon – Clinical Feasibility Study of the BariTon System in Obese Patients 22

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 23

Endo-Luminal Surgery Tool – Product Status 23

Endo-Luminal Surgery Tool – Product Description 23

Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 24

Fiber-Top Controlled Adaptable Stiffness Needle – Product Status 24

Fiber-Top Controlled Adaptable Stiffness Needle – Product Description 24

Low-friction Surgical Grasper – Product Status 25

Low-friction Surgical Grasper – Product Description 25

Distalmotion SA Pipeline Products & Ongoing Clinical Trials Overview 26

Disposable Surgical Device – Product Status 26

Disposable Surgical Device – Product Description 26

Reusable Surgical Device – Product Status 27

Reusable Surgical Device – Product Description 27

Eindhoven University of Technology Pipeline Products & Ongoing Clinical Trials Overview 28

PITON Teleoperated Steerable Needle System – Product Status 28

PITON Teleoperated Steerable Needle System – Product Description 28

ES Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29

CLI Endostapler – Product Status 29

CLI Endostapler – Product Description 29

Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Magnetic Anchoring And Guidance System – Product Status 30

Magnetic Anchoring And Guidance System – Product Description 30

Ezisurg Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Cavity Mirror System – Product Status 31

Cavity Mirror System – Product Description 31

GT Metabolic Solutions Pipeline Products & Ongoing Clinical Trials Overview 32

MagDI System – Metabolic Surgery – Product Status 32

MagDI System – Metabolic Surgery – Product Description 32

GT Metabolic Solutions – Ongoing Clinical Trials Overview 33

MagDI System – Metabolic Surgery – Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic MagDI System in Canada to Achieve Duodeno-Ileal Diversion in Adults With Obesity and With or Without Type 2 Diabetes Mellitus (MagDI Canada Study) 34

MagDI System – Metabolic Surgery – Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions DI Bio-fragmentable Magnetic Anastomosis System to Achieve Duodeno-Ileostomy Diversion in Adults With Obesity and Type 2 Diabetes Mellitus 34

MagDI System – Metabolic Surgery – Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions DI Biofragmentable Magnetic Anastomosis System (Magnet System, DI Biofragmentable) to Achieve Jejuno-Ileal Diversion in Adults With Obesity and Type 2 Diabetes Mellitus: MJI Study 34

MagDI System – Metabolic Surgery – Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions Magnet System, DI Biofragmentable (MagDI System) in Australia to Achieve Duodeno-Ileostomy Diversion in Adults With Obesity and With Type 2 Diabetes Mellitus (MagDI Australia Study) 35

MagDI System – Metabolic Surgery – Creation of Side-to-Side Compression Anastomosis Using the GT Metabolic Solutions Magnet System, GJ Biofragmentable to Achieve Gastro-Ileal or Gastro-Jejunal Diversion in Adults with Obesity 35

Intuitive Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 36

Next-Generation Multiport System – Product Status 36

Next-Generation Multiport System – Product Description 36

Jiangsu Jiyuan Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 37

Disposable Gynecological Minimally Invasive Surgical Instrument – Product Status 37

Disposable Gynecological Minimally Invasive Surgical Instrument – Product Description 37

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 38

Dexterous Tool – Surgical Procedures – Product Status 38

Dexterous Tool – Surgical Procedures – Product Description 38

Lapovations LLC Pipeline Products & Ongoing Clinical Trials Overview 39

Second Generation AbGrab – Product Status 39

Second Generation AbGrab – Product Description 39

LXS Inc Pipeline Products & Ongoing Clinical Trials Overview 40

Catheter Device – Product Status 40

Catheter Device – Product Description 40

Medacta Group SA Pipeline Products & Ongoing Clinical Trials Overview 41

Robotic Leg Positioner – Product Status 41

Robotic Leg Positioner – Product Description 41

Osaka University Pipeline Products & Ongoing Clinical Trials Overview 42

Minimal Access Surgical Instrument – Product Status 42

Minimal Access Surgical Instrument – Product Description 42

Patch Clamp Med Tech Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Patchclamp Surgical Device – Product Status 43

Patchclamp Surgical Device – Product Description 43

Prana Thoracic Inc Pipeline Products & Ongoing Clinical Trials Overview 44

ThoraCore System – Product Status 44

ThoraCore System – Product Description 44

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 45

Surgical Master-Slave Manipulator – Product Status 45

Surgical Master-Slave Manipulator – Product Description 45

Qingdao Jianxin Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 46

Inteliigent Twin-Engine Dynamic Hybrid Energy Surgery System – Product Status 46

Inteliigent Twin-Engine Dynamic Hybrid Energy Surgery System – Product Description 46

Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 47

Surgical Device – Minimally Invasive Surgery – Product Status 47

Surgical Device – Minimally Invasive Surgery – Product Description 47

Ruilong Ruilong Nuofu (Shanghai) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 48

MIS System – Product Status 48

MIS System – Product Description 48

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 49

Minimally Invasive Device – Gastrointestinal Bleeding – Product Status 49

Minimally Invasive Device – Gastrointestinal Bleeding – Product Description 49

UltraSurge Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 50

UltraSurge’s Device – Product Status 50

UltraSurge’s Device – Product Description 50

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 51

Transcolonic Overtube For NOTES – Product Status 51

Transcolonic Overtube For NOTES – Product Description 51

University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 52

Interleaved Continuum-rigid Manipulator – Product Status 52

Interleaved Continuum-rigid Manipulator – Product Description 52

Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview 53

ArthroTense – Product Status 53

ArthroTense – Product Description 53

VenX Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54

VenX Reach – Product Status 54

VenX Reach – Product Description 54

Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 55

Magnetoelectric Device – Product Status 55

Magnetoelectric Device – Product Description 55

West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 56

Steerable Drill-Driver – Product Status 56

Steerable Drill-Driver – Product Description 56

Steerable Plate Positioner-Stabilizer – Product Status 57

Steerable Plate Positioner-Stabilizer – Product Description 57

Glossary 84

Figures

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Stage of Development 11

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Territory 12

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Regulatory Path 13

Minimally Invasive Surgical (MIS) devices – Pipeline Products by Estimated Approval Date 14

Minimally Invasive Surgical (MIS) devices – Ongoing Clinical Trials 15

Frequently asked questions

Minimally Invasive Surgical (MIS) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Minimally Invasive Surgical (MIS) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Minimally Invasive Surgical (MIS) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Minimally Invasive Surgical (MIS) Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.